Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070184 · ClinicalTrials.gov registry record · Phase 2
Race, Natriuretic Peptides and Physiological Perturbations
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT03070184: Completed Phase 2 study, sponsored by University of Alabama at Birmingham.
NCT03070184 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03070184, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of the study is to understand the origins of differential response to beta-blockers in African-Americans and may provide insight regarding racial differences in cardiovascular risk.
Primary Outcome
Mean percentage change in plasma BNP concentrations in response to 6 weeks of Beta-Blocker between Black participants and White participants
Interventions
- OTHER Exercise capacity VO2 max determination
- DIETARY_SUPPLEMENT Standardized meals
- OTHER Exercise challenge
- DRUG Metoprolol Succinate ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-04-30 |
| Est. Completion | 2024-04-30 |
| Phase | Phase 2 |
What the finished NCT03070184 record still lists
NCT03070184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 4 interventions - of which Exercise capacity VO2 max determination is the first listed.
NCT03070184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03070184 about?
NCT03070184 is a clinical study titled "Race, Natriuretic Peptides and Physiological Perturbations". The purpose of the study is to understand the origins of differential response to beta-blockers in African-Americans and may provide insight regarding racial differences in cardiovascular risk.
What is the current status of trial NCT03070184?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2017-04-30. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03070184?
The interventions under investigation include: Exercise capacity VO2 max determination (OTHER), Standardized meals (DIETARY_SUPPLEMENT), Exercise challenge (OTHER), Metoprolol Succinate ER (DRUG).
Who is sponsoring clinical trial NCT03070184?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03070184's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI